October 25, 2021

TELES Aktiengesellschaft Informationstechnologien: Strategic investment in GVL Rechenzentrum GmbH

Berlin (25.10.2021/19:25) – TELES AG Informationstechnologien (ISIN DE000A289B07 / WKN A289B0) acquires the majority of the pharmacy computing center GVL Rechenzentrum GmbH (GVL). TELES uses its many years of technological experience, especially in a market that is changing from analog to digital, for an expansion into the digitization of the pharmaceutical market. The competence of TELES for the secure management of large amounts of data, including their analysis, is also in demand in the pharmaceutical market.

 GVL Rechenzentrum GmbH, together with other medium-sized pharmacy data centers, develops products and tools that significantly simplify the handling of the electronic prescription for pharmacies and health insurance companies that will soon be required by law and make new business models such as clinical health services research economical.

With GVL and TELES, two companies will be brought together that will benefit from digitization. TELES sees the pharmaceutical industry as an area of ​​expansion.

TELES is a company that develops and maintains software for infrastructure providers (telecommunications, pharmaceuticals). Millions of people in around 50 countries use TELES products.

The Management Board


Important instructions

This publication constitutes neither an offer to sell nor a solicitation to buy securities. This announcement may not be published, distributed or transmitted in the United States of America, Australia, Japan or Canada. This release does not constitute an offer to purchase securities or a solicitation of an offer to purchase securities of TELES AG Informationstechnologien (the 'Shares') in the United States, Germany, or other states.